Global Healthcare Conference

Scott Gottlieb, M.D. Former
Commissioner of the FDA

Scott Gottlieb, MD, is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is currently a senior fellow at the American Enterprise Institute for Public Policy Research and a partner at the venture capital firm New Enterprise Associates.

Under his leadership, the FDA advanced new frameworks for the modern oversight of gene therapies, cell-based medicines, and digital health devices. The agency implemented new reforms to standardize drug reviews and made historic improvements in post-market data collection and the use of real-world evidence. He promoted policies to reduce death and disease from tobacco, improve food safety, and aggressively confront addiction crises. The agency’s prolific advances in new policy distinguished his tenure as FDA Commissioner, along with a record-setting number of approvals for novel drugs, medical devices, and generic medicines.

Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and, before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services. He is the author of the New York Times bestselling book “Uncontrolled Spread: Why Covid-19 Crushed Us and How We Can Defeat the Next Pandemic” and is a regular contributor to CNBC and CBS News’ Face the Nation. Dr. Gottlieb serves on the board of directors of publicly traded companies Pfizer, Inc., Illumina, Inc., and TempusAI.

Dr. Gottlieb is an elected member of the National Academy of Medicine and completed medical school and a residency in internal medicine at the Mount Sinai School of Medicine, where he currently serves on the executive committee of the Mount Sinai Health System’s board of directors and co-chairs the board’s education committee. He graduated from Wesleyan University, where he majored in economics, and currently serves on the university’s board of directors. Dr. Gottlieb lives in Connecticut with his wife and three daughters.

Vivian S. Lee, M.D., Ph.D., M.B.A.
Observations from the Front Lines of the AI Healthcare Revolution

Vivian S. Lee, M.D., Ph.D., M.B.A., is a physician and health tech executive, scholar, and author of The Long Fix: Solving America's Health Care Crisis with Strategies that Work for Everyone. An Executive Fellow at Harvard Business School and Senior Lecturer at Harvard Medical School, she focuses on AI and innovation at the intersection of tech, climate change, and healthcare. Lee served as the founding President of Health Platforms at Verily (Alphabet), where she built multiple substantial health tech start-ups, including virtual disease management, precision risk insurance, and pandemic management, among others. Prior to Verily, Lee was Dean of the medical school and CEO of the University of Utah Health, a system highly regarded for its exceptional quality, patient experience, and delivery innovation. Before that, she was Chief Scientific Officer at NYU Langone Medical Center. Dr. Lee is a magna cum laude graduate of Harvard, received a D.Phil in medical engineering from Oxford as a Rhodes Scholar, earned her M.D. with honors from Harvard, and her MBA from NYU. Elected to the National Academy of Medicine, Lee serves on the Board of Directors of the Commonwealth Fund, Boston Children’s Hospital, the Joint Commission, and Zions Bancorporation.